Arena Pharmaceuticals Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. Arena focused on discovering drugs that act on G protein-coupled receptors (GPCRs).

Mar 11, 2022 · NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Arena Pharmaceuticals, a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.

May 2, 2023 · Pfizer has taken the broom to three midstage medicines from the acquisition of Arena Pharmaceuticals, deciding that etrasimod alone was worthy of the biotech’s $6.7 billion price tag.

Dec 13, 2021 · Pfizer said on Monday it would buy drug developer Arena Pharmaceuticals for $6.7 billion in cash.

Dec 13, 2021 · “We’re delighted to announce Pfizer’s proposed acquisition of Arena, recognizing Arena’s potentially best in class S1P molecule and our contribution to addressing unmet needs in immune-mediated inflammatory diseases,” said Amit D. Munshi, President and Chief Executive Officer of Arena.

Dec 13, 2021 · This release contains forward-looking information about Pfizer’s proposed acquisition of Arena, Arena’s pipeline portfolio, including its molecules etrasimod, temanogrel and APD418 and ...

Mar 14, 2022 · Pfizer has concluded the takeover of the complete outstanding shares, options and restricted stock units of clinical-stage firm Arena Pharmaceuticals for an equity price of nearly $6.7bn or $100 for each share in cash. In December last year, Pfizer entered a definitive agreement to acquire Arena.

Dec 13, 2021 · Pfizer has agreed to acquire Arena Pharmaceuticals for about $6.7 billion in a deal that validates the San Diego biotech’s plan to reshape itself around a portfolio of inflammation drugs. Pfizer will buy Arena for $100 per share in cash, more than double the …

Dec 14, 2021 · Pfizer has agreed to acquire Arena Pharmaceuticals for approximately $6.7 billion, the companies said today, in a deal designed to expand the buyer’s immuno-inflammatory disease pipeline, led by Arena’s Phase II/II lead candidate etrasimod.

Dec 14, 2021 · Arena Pharmaceuticals. Arena, a clinical-stage firm exploring unique potential treatments for the treatment of multiple immuno-inflammatory illnesses, has agreed to be acquired by Pfizer under a definitive agreement.